Delta Lloyd’s Quest Diagnostics DGX Stock Holding History

Delta Lloyd’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$2.36M	Buy	21,271 +4,153	+24%	+$439K	0.07%	263
2017 Q1	$1.68M	Hold	17,118	–	–	0.05%	290
2016 Q4	$1.57M	Buy	17,118 +6,830	+66%	+$589K	0.05%	294
2016 Q3	$871K	Hold	10,288	–	–	0.03%	440
2016 Q2	$838K	Hold	10,288	–	–	0.03%	423
2016 Q1	$735K	Hold	10,288	–	–	0.02%	462
2015 Q4	$732K	Hold	10,288	–	–	0.03%	455
2015 Q3	$632K	Hold	10,288	–	–	0.02%	499
2015 Q2	$746K	Buy	10,288 +3,613	+54%	+$267K	0.02%	444
2015 Q1	$513K	Hold	6,675	–	–	0.02%	452
2014 Q4	$448K	Hold	6,675	–	–	0.01%	483
2014 Q3	$405K	Hold	6,675	–	–	﹤0.01%	483
2014 Q2	$392K	Buy	6,675 +2,454	+58%	+$144K	0.01%	473
2014 Q1	$244K	Hold	4,221	–	–	0.01%	553
2013 Q4	$226K	Hold	4,221	–	–	0.01%	551
2013 Q3	$261K	Hold	4,221	–	–	0.01%	490
2013 Q2	$256K	Buy	+4,221	New	+$251K	0.01%	464

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Delta Lloyd's DGX Position: Q2 2017 in Review

Delta Lloyd increased its Quest Diagnostics (DGX) stake by 24% in Q2 2017, buying an estimated $439K and bringing the position to 21,271 shares worth $2.36M. The position accounts for 0.07% of the portfolio, ranked #263.

Delta Lloyd first reported a position in DGX in Q2 2013 and has held it in 17 quarters since. 643 funds tracked by Wall St. Rank hold DGX as of Q2 2017.

Delta Lloyd held 21,271 shares of Quest Diagnostics worth $2.36M as of Q2 2017.
Delta Lloyd bought 4,153 Quest Diagnostics shares in Q2 2017, an estimated $439K.
Quest Diagnostics made up 0.07% of Delta Lloyd's portfolio in Q2 2017, its #263 holding.
Delta Lloyd first reported a position in Quest Diagnostics in Q2 2013 and has held it in 17 quarters since.
643 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2017.

Based on Delta Lloyd's 13F filing for Q2 2017, filed 9 Aug 2017.